<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/asnd" ></link>
<id>urn:uuid:d12bd973-aae3-4e35-fe2c-8884578ca795</id>
<updated>2026-06-18T11:03:36-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ASND: SMITH SCOTT THOMAS (VP,CFO) Bought (B) 100 Shares of ASCENDIS PHARMA A S for $219.00 on 6/2</title>
<link href="http://www.insiderinsights.com/company/asnd/ascendis-pharma-a-s/id-6416708" ></link>
<id>urn:uuid:234ca85e-6c4b-72ba-7060-5bff214755b0</id>
<updated>2026-06-02T16:25:15-04:00</updated>
<summary type="html" ><![CDATA[ASCENDIS PHARMA A S (ASND). Recent Price: $218.06. Mkt Cap:14.3B. 10D Vol: 577,150]]></summary>
</entry>
<entry>
<title>ASND: BIENAIME JEAN JACQUES (DIR) Bought (B) 500 Shares of ASCENDIS PHARMA A S for $222.30-$223.50 on 5/29</title>
<link href="http://www.insiderinsights.com/company/asnd/ascendis-pharma-a-s/id-6415540" ></link>
<id>urn:uuid:682e564e-6acd-cfb0-ba14-a5d525e01b88</id>
<updated>2026-06-01T16:11:13-04:00</updated>
<summary type="html" ><![CDATA[ASCENDIS PHARMA A S (ASND). Recent Price: $218.06. Mkt Cap:14.3B. 10D Vol: 577,150]]></summary>
</entry>
<entry>
<title>ASND: SMITH SCOTT THOMAS (VP,CFO) Bought (B) 250 Shares of ASCENDIS PHARMA A S for $223.32 on 5/29</title>
<link href="http://www.insiderinsights.com/company/asnd/ascendis-pharma-a-s/id-6415542" ></link>
<id>urn:uuid:a853c43e-16a4-6c71-ee3f-bd3a8caf02e1</id>
<updated>2026-06-01T16:10:28-04:00</updated>
<summary type="html" ><![CDATA[ASCENDIS PHARMA A S (ASND). Recent Price: $218.06. Mkt Cap:14.3B. 10D Vol: 577,150]]></summary>
</entry>
<entry>
<title>ASND: SMITH SCOTT THOMAS (VP,CFO) Filed a Form 3, Becoming a Registered Insider at ASCENDIS PHARMA A S With Initial Direct Holdings of 4,017</title>
<link href="http://www.insiderinsights.com/company/asnd/ascendis-pharma-a-s/id-6415505" ></link>
<id>urn:uuid:cb2a56aa-eb20-277a-ca9d-c20bf0aa90b7</id>
<updated>2026-06-01T16:09:57-04:00</updated>
<summary type="html" ><![CDATA[ASCENDIS PHARMA A S (ASND). Recent Price: $218.06. Mkt Cap:14.3B. 10D Vol: 577,150]]></summary>
</entry>
<entry>
<title>ASND: BIENAIME JEAN JACQUES (DIR) Bought (B) 400 Shares of ASCENDIS PHARMA A S for $236.24-$239.37 on 5/26</title>
<link href="http://www.insiderinsights.com/company/asnd/ascendis-pharma-a-s/id-6412773" ></link>
<id>urn:uuid:c8ffab45-e852-99a9-4975-84251349caeb</id>
<updated>2026-05-27T16:05:26-04:00</updated>
<summary type="html" ><![CDATA[ASCENDIS PHARMA A S (ASND). Recent Price: $218.06. Mkt Cap:14.3B. 10D Vol: 577,150]]></summary>
</entry>
<entry>
<title>ASND: JENSEN FLEMMING STEEN (O) Sold (S) 19,460 Shares of ASCENDIS PHARMA A S for $238.49 on 5/11</title>
<link href="http://www.insiderinsights.com/company/asnd/ascendis-pharma-a-s/id-6400702" ></link>
<id>urn:uuid:32445ef5-52a1-a0b1-7e68-92597391155a</id>
<updated>2026-05-12T16:08:41-04:00</updated>
<summary type="html" ><![CDATA[ASCENDIS PHARMA A S (ASND). Recent Price: $218.06. Mkt Cap:14.3B. 10D Vol: 577,150]]></summary>
</entry>
</feed>